China’s healthcare market is one of the biggest opportunities I see right now for foreign brands. The numbers are striking, and consumer behavior has shifted dramatically since 2023. I have worked with brands trying to enter this space for over 15 years. The ones who succeed understand one thing: this is not a single market. It is a layered market with very different buyers, very different channels, and fast-moving rules.
This article gives you a clear picture of where the market stands in 2026, which channels drive sales, and what foreign brands need to know before investing.
Overview of the Chinese Healthcare Market (2026)
Market Size and Growth
- Total healthcare market projected to reach RMB 20 trillion by 2026
- Driven by:
- 323 million citizens aged 60 and above, representing 23% of the total population
- Rise of chronic diseases including diabetes and hypertension
- A health-conscious middle class aged 25 to 45 spending more on prevention
- Post-COVID demand for preventive care, wellness, and self-care tools
The functional food segment alone is projected to reach 436.6 billion yuan by 2026, growing at a CAGR of 5.8% since 2022. Health and wellness food ingredients are on track for USD 85 to 95 billion in 2026, with projections reaching USD 160 to 185 billion by 2035.
Key Growth Segments
- Health supplements: vitamins, probiotics, sleep aids, collagen, cognitive health
- Smart health devices: wearables, glucose monitors, blood pressure trackers
- Online pharmacy services and e-prescription platforms
- AI-powered diagnostics and virtual consultations
- Mental health and stress management products
The Silver Economy: China’s Most Underestimated Health Opportunity
Most foreign brands focus on China’s young consumers. That is a mistake if you sell health products.
The silver economy, spending by consumers aged 60 and above, reached approximately RMB 7 trillion in 2023 and 2024. The 36Kr Research Institute projects it will expand to RMB 30 trillion by 2035. Brain health supplements, bone and joint products, and anti-aging categories are the top spending priorities for this segment in 2026.
I have seen brands fail because they designed their messaging for young Chinese consumers when their actual buyers were 55-year-old urban professionals worried about osteoporosis and cognitive decline. These consumers have disposable income. They trust clinical proof over lifestyle imagery.
What works for the silver segment:
- WeChat mini-programs with doctor recommendations and detailed ingredient explanations
- KOL content from health professionals, not beauty influencers
- Tmall flagship stores with strong product certification and clinical study references
- Membership programs built around long-term use and subscription models
At Cosmetics China Agency, we have worked with brands that underestimated this segment and came back six months later asking us to fix their positioning. Get it right from the start.
Douyin, XHS, and Live Commerce in Health (2026)
The data is clear: Douyin is now the primary sales channel for health supplements in China.
In the cross-border e-commerce segment for health products, Tmall holds 42.2% market share and Douyin sits at 40.9%. That gap is closing fast. Haleon, the parent company of Centrum multivitamins, reported 100% growth in its Douyin business in Q1 2026 and plans to triple content output and double its KOL count before year-end.
Top CBEC performers on Douyin include Swisse, Move Free, OXYENERGY, Vita Green, and OLLY, all with GMV exceeding RMB 100 million. Over 70% of their leading sales come from Douyin. Not Tmall. Douyin.
The format that converts: short educational videos explaining one ingredient, its benefits, and the clinical backing, followed by a live-stream session where a health KOL answers viewer questions and sells directly. Ergothioneine, a relatively obscure antioxidant, generated RMB 200 million in sales in 2025 almost entirely through this model on Douyin.
Xiaohongshu (XHS) plays a different role. It is the discovery and trust-building platform. Consumers find a product through community posts and UGC reviews. They check the ingredient list. They read comments. Then they buy on Tmall or Douyin. Any brand skipping XHS is missing a critical step in the purchase journey.
For brands building a position in China’s health market, our guides on Xiaohongshu marketing and Douyin advertising break down exactly how to approach both platforms for health and wellness categories.
The Role of AI in Chinese Healthcare (2026)
- AI helps diagnose, monitor, and personalize health services at scale
- Applications include:
- Symptom checkers on JD Health and Ping An Good Doctor
- Smart wearables giving real-time health alerts and supplement suggestions
- Chatbots and triage tools for clinics and pharmacies
- Image-based diagnostics in dermatology and radiology
- AI also powers marketing personalization on e-commerce, with product suggestions based on search and purchase history
China’s AI-in-healthcare market reached USD 1.58 billion in 2025 and is expected to reach USD 9.7 billion by 2034, growing at a CAGR of 21.66%. The government has committed CNY 15 to 20 billion over five years to deploy AI tools across 50 hospitals and 500 township clinics starting in 2026.
For brands, this shift matters in one specific way. Consumers are increasingly asking AI assistants, such as Doubao (ByteDance) and Kimi, what supplement to take for a specific health concern. If your brand appears in those answers, your sales will reflect it. If you are invisible on these platforms, you are losing ground to competitors who have invested in structured content and clinical credibility.
Consumer Concern and Health Consciousness
Consumer health is a priority in every market. China stands out because the shift from reactive to preventive care is happening faster here than anywhere else I have tracked.
According to a report published by McKinsey & Co, the country’s healthcare market was valued at $357 billion in 2011 and has grown at a CAGR of around 12% since then. The structural reasons behind this growth have not changed. They have accelerated.
- Improvement in living standards and urban disposable income
- Growing health consciousness among local consumers, especially post-COVID
- Increased personal investment in long-term well-being
- Introduction of nutrition supplements and functional foods into everyday purchasing habits
- Strong appetite for imported brands seen as higher quality and better regulated
Australian and US supplement brands benefit from strong quality perception among Chinese consumers. Cross-border e-commerce makes this accessible: the CBEC market for health products was valued at USD 566 million in 2025 with 20% year-on-year growth.
For brands looking to enter through Tmall Global, the entry requirements are clear and consumer trust is high. It remains the most reliable first channel for foreign health brands entering China today.
Latest Healthcare Trends in China
- Preventive health first: Immunity, digestion, sleep, and stress products are the top growth categories.
- Mental wellness is mainstream: Sleep aids, focus supplements, and mood products are surging, especially among professionals aged 25 to 40.
- Functional ingredients matter: Chinese consumers demand ingredient transparency, efficacy, and clinical proof. Vague claims do not sell.
- AI-powered health services:
- AI triage systems on JD Health and Ping An Good Doctor
- AI-enabled health check kiosks in Tier 2 and 3 cities
- AI wearable integrations for real-time diagnostics and personalized product suggestions
- Digitally connected health journeys: Online doctor consultations lead directly to e-prescriptions, which link to same-day delivery. The full journey happens inside one platform.
- CBEC remains vital for imported supplements and devices.
How to Enter China’s Healthcare Market in 2026
I will be direct about what I see working right now.
First, you need clinical credibility. The Chinese consumer is not naive. They check ingredient lists, look for CFDA approval or CBEC registration, and read reviews on XHS before buying. Without credibility, no amount of advertising will convert.
Second, you need a platform strategy matched to your product. Health supplements for young professionals: Douyin live-stream plus XHS community content. Products for the silver economy: WeChat mini-programs plus Tmall flagship. Medical devices: JD Health plus professional KOL partnerships.
Third, you need KOL partnerships that are genuinely relevant to health. A beauty influencer with 10 million followers will not sell your joint supplement. A registered dietitian with 200,000 XHS followers will.
At Cosmetics China Agency, we have built campaigns for brands entering the health space through all of these channels. The brands that scale fastest invest in credibility before they invest in volume.
Our digital marketing agency for China specializes in cosmetics brands. Contact us for a free audit of your China strategy.
